The Merck vaccine is a regimen designed to prevent the onset of shingles, which is caused by the reemergence of dormant chicken pox virus.The U.S. Food and Drug Administration (FDA) has extended the ...

NJBIZ, New Jersey’s leading business journal, provides 24/7 business news coverage and events honoring top business professionals.

The order mandated all remaining plaintiffs to produce similar clinical evidence to support their claims. Merck countered that the cases lacked merit without conclusive evidence linking the vaccine to ...

For all the attention in the media about potential side effects of vaccines like Merck’s HPV vaccine Gardasil, not enough time or attention has been paid congratulating Merck for its shingles homerun, ...

Oct 18 (Reuters) - The federal trial judge overseeing a four-year-old multidistrict litigation over Merck’s Zostavax shingles vaccine decided in March 2022 that it was time for plaintiffs to put up or ...

The FDA on Friday granted approval to Merck’s Zostavax vaccine to treat patients over age 60 with the often-painful disease shingles. “This vaccine gives healthcare providers an important tool that ...

WHITEHOUSE STATION, N.J., May 15, 2008 - The U.S. Centers for Disease Control and Prevention (CDC) has adopted the unanimous recommendation of its Advisory Committee on Immunization Practices (ACIP) ...

WASHINGTON (Reuters) - U.S. health officials on Thursday recommended that people 60 and older get Merck & Co Inc's vaccine Zostavax to protect against shingles, a viral infection that causes a painful ...

NEW YORK, Oct 21 (Reuters) - In a huge study aimed at broadening the use of Merck & Co's shingles vaccine, Zostavax reduced the incidence of the painful disease by 70 percent compared with a placebo ...

U.S. regulators have approved a new, more effective vaccine to prevent painful shingles, which is caused by the chickenpox virus. Drugmaker GlaxoSmithKline said the Food and Drug Administration ...

October is shaping up to be a momentous month for GlaxoSmithKline’s new shingles vaccine, Shingrix. The Food and Drug Administration may approve the vaccine for the U.S. market by the end of this week ...

BOSTON (MarketWatch) -- Merck has received U.S. regulatory approval for its vaccine Zostavax for the prevention of shingles in people aged 60 years or older. Shingles, which is caused by the ...